Age-related deficits in context discrimination learning in Ts65Dn mice that model down syndrome and alzheimer's disease

Behavioral Neuroscience

Volumn 115, Issue 6, 2001, Pages 1239-1246

  Hyde, Lynn A ^a,b   Crnic, Linda S ^a  

^a Children's Hospital Colorado   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; AGE; AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DISCRIMINATION LEARNING; DOWN SYNDROME; LEARNING DISORDER; MALE; MOUSE; NONHUMAN; SEPTUM PELLUCIDUM;

EID: 0035208315     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.115.6.1239     Document Type: Article

References (67)

1. Increased kynurenic acid levels and decreased brain kynurenine aminotransferase I in patients with Down syndrome
2. Growth and development of the brain in Down syndrome
3. Association of phenotypic abnormalities of Down syndrome with an imbalance of genes on chromosome 21
4. Neurochemical correlates of dementia severity in Alzheimer's disease: Relative importance of the cholinergic deficits
5. Localization of a retroviral element within the rd gene coding for the β subunit of cGMP phosphodiesterase
6. The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome
7. Abnormalities of the nucleus basalis in Down's syndrome
8. Ibotenate lesions of the hippocampus impair spatial learning but not contextual fear conditioning in mice
9. Ts65Dn model of Down syndrome (DS): Radial maze learning and contextual conditioning
10. Mouse models of Down syndrome
11. Segmental trisomy of murine chromosome 16: A new model system for studying Down syndrome
12. Segmental trisomy as a mouse model for Down syndrome
13. Cortical biopsy in Alzheimer's disease: Diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations
14. Spatial memory deficits in segmental trisomic Ts65Dn mice
15. Impaired spatial working and reference memory in segmental trisomy (Ts65Dn) mice
16. Differential correlation between neurochemical deficits, neuropathology, and cognitive status in Alzheimer's disease
17. Reverse relationship between β-amyloid precursor protein and β-amyloid peptide plaques in Down's syndrome versus sporadic/familial Alzheimer's disease
18. Presenile dementia in Down's syndrome: Ultrastructural identity with Alzheimer's disease
19. A behavioral assessment of Ts65Dn mice: A putative Down syndrome model
20. Neurochemical studies of early-onset Alzheimer's disease
21. The cholinergic hypothesis of Alzheimer's disease: A review of progress
22. The dorsal hippocampus is essential for context discrimination but not for contextual conditioning
23. Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue
24. Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome
25. Alzheimer's disease in Down syndrome: Clinicalneuropathological observations
26. Evidence against the involvement of reactive oxygen species in the pathogenesis of neuronal death in Down's syndrome and Alzheimer's disease
27. Down's syndrome and Alzheimer's dementia: Defining an association
28. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome: Quantitative regional analysis and comparison with Alzheimer's disease
29. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome
30. Ts65Dn mice, a model for Down syndrome, have deficits in context discrimination learning suggesting impaired hippocampal function
31. Neuropathological changes in Down's syndrome hippocampal formation
32. Neuropathological changes in the nucleus basalis correlate with clinical measures of dementia
33. On the role of the hippocampus in learning and memory in the rat
34. 3H] Vesamicol binding in human brain cholinergic deficiency disorders
35. Characterization of sensorimotor performance, reproductive and aggressive behaviors in segmental trisomic 16 (Ts65Dn) mice
36. Mouse molecular cytogenetic resource: 157 BACs link the chromosomal and genetic maps
37. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease
38. Sequence of deposition of heterogeneous amyloid β-peptides and APO E in Down syndrome: Implications for initial events in amyloid plaque formation
39. The pathological association between Down syndrome and Alzheimer disease
40. Cerebral amyloidosis, ageing and Alzheimer's disease: A contribution from studies on Down's syndrome
41. Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes
42. Pathological evidence for neurotransmitter deficits in Down's syndrome of middle age
43. Central cholinergic pathways in the rat: An overview based on an alternative nomenclature (Ch1-Ch6)
44. Cholinergic deficits contribute to behavioral disturbance in patients with dementia
45. Place navigation impaired in rats with hippocampal lesions
46. Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria terminalis in aging. Alzheimer's disease and Down's syndrome
47. Neural and cognitive development in Down syndrome
48. Alzheimer's disease: A correlative study
49. Cholinergic receptors in cognitive disorders
50. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia
51. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning
52. A mouse model for Down syndrome exhibits learning and behaviour deficits
53. Ontogeny of spatial discrimination in mice: A longitudinal analysis in the modified openfield with objects
54. Relationship between plaques, tangles, and dementia in Down syndrome
55. Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome
56. Similar deficits of central histaminergic system in patients with Down syndrome and Alzheimer's disease
57. Reduction in TrkA-immunoreactive neurons is not associated with an overexpression of galaninergic fibers within the nucleus basalis in Down's syndrome
58. Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: A positron emission tomography study
59. Alzheimer's disease and senile dementia as seen in mongoloids: Neuropathological observations
60. The cholinergic deficit in Alzheimer's disease
61. Alzheimer's disease: Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities
62. Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis
63. Plaques, tangles, and dementia in Down syndrome
64. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome
65. Regional brain 5-hydroxytryptamine levels are reduced in senile Down's syndrome as in Alzheimer's disease
66. Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome
67. Alzheimer-like cholinergic deficiency in Down syndrome